Kondapa Naidu Bobba, PhD, is first author of “Evaluation of 134Ce/134La as a PET Imaging Theranostic Pair For 225Ac -Radiotherapeutics,” a Journal of Nuclear Medicine (JNM) article published May 18 that discusses the development of a robust radiolabeling methodology and applied optimized method for utilizing prostate cancer targeting agents PSMA-617 and antibody YS5. Dr. Bobba, an assistant professional researcher in the UC San Francisco Department of Radiology & Biomedical Imaging, performed his research investigations with PI Robert Flavell, MD, PhD, chief of Molecular Imaging and Therapeutics, and the corresponding author. Additional authors included Henry VanBrocklin, PhD, Youngho Seo, PhD, as well as colleagues from UCSF and the University of Virginia.
The JNM article addresses the challenge of dosing with the therapeutic nuclide 225Ac due to low emission rates of…
